Traditional means to curb pathogenic infections during primary
production included the supplementation of antimicrobials in animal
feed, which leads to selective pressure and subsequently the
development of resistant bacteria. This resistance makes treating
infections with common antimicrobials less effective in both human
and veterinary settings. As a result, alternative strategies to
prevent and control infections in commercial poultry flocks is
increasingly becoming more necessary. One such method that has
been gaining popularity is the use of bacteriophage therapy. The
aim of this review is to examine the impact of antimicrobials on the
farm that has led to antimicrobial and multi drug resistant Salmonella
and Campylobacter, primarily focusing on chicken production
as well as the potential use of bacteriophages as a source of biocontrol
along the farm-to-fork pathway.